Market Cap 430.71M
Revenue (ttm) 143.06M
Net Income (ttm) 24.78M
EPS (ttm) N/A
PE Ratio 18.15
Forward PE N/A
Profit Margin 17.32%
Debt to Equity Ratio 5.31
Volume 29,600
Avg Vol 97,930
Day's Range N/A - N/A
Shares Out 22.66M
Stochastic %K 79%
Beta 0.45
Analysts Strong Buy
Price Target N/A

Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers market...

Industry: Health Information Services
Sector: Healthcare
Phone: 402 475 2525
Address:
1245 Q Street, Lincoln, United States
DavyDaveCharts
DavyDaveCharts Dec. 14 at 4:45 PM
$NRC watching 18s for potential breaker. weekly chart.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 12 at 1:45 AM
$NRC Share Price: $17.44 Contract Selected: Jun 18, 2026 $20 Calls Buy Zone: $0.68 – $0.84 Target Zone: $1.27 – $1.55 Potential Upside: 76% ROI Time to Expiration: 188 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:33 PM
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 11 at 11:24 AM
$NRC Share Price: $14.49 Contract Selected: Jun 18, 2026 $15 Calls Buy Zone: $0.99 – $1.23 Target Zone: $1.58 – $1.93 Potential Upside: 50% ROI Time to Expiration: 218 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Oct. 31 at 6:50 PM
$NRC popped 12% even with earnings down — here’s why investors are cheering. 📊 Higher interest costs weighed on Q3, but margin gains, solid cash flow, and a 33% dividend hike more than balanced the hit. See the full picture behind NRC Health’s surprising strength 👉 https://www.zacks.com/stock/news/2782887/nrc-stock-up-12-despite-q3-earnings-down-yy-on-rising-interest-costs?cid=sm-stocktwits-2-2782887-teaser-18926&ADID=SYND_STOCKTWITS_TWEET_2_2782887_TEASER_18926
0 · Reply
ZacksResearch
ZacksResearch Oct. 31 at 5:50 PM
Is $NRC Health’s surge a sign of things to come? 🚀 📈 Stock up 12.3% since earnings, outpacing the S&P 500 💰 Adjusted EBITDA jumped 11%, with margins expanding to 31.4% 🔄 Total Recurring Contract Value climbed 8%, marking strong subscription growth Despite declines in adjusted net income and total revenues, discover what’s driving NRC’s momentum here 👉 https://www.zacks.com/stock/news/2782887/nrc-stock-up-12-despite-q3-earnings-down-yy-on-rising-interest-costs?cid=sm-stocktwits-2-2782887-body-18888&ADID=SYND_STOCKTWITS_TWEET_2_2782887_BODY_18888
0 · Reply
StockScanners
StockScanners Oct. 29 at 2:09 AM
$NRC keep watch if this hold above 12.85
0 · Reply
topstockalerts
topstockalerts Oct. 28 at 4:20 PM
$NRC curling back up
0 · Reply
Uneducated_Trader
Uneducated_Trader Oct. 28 at 2:04 PM
$NRC another stock AI told me to buy on Friday. Thanks AI 👍
0 · Reply
InvisibleHandTrades
InvisibleHandTrades Oct. 5 at 2:12 PM
$NRC Technology services micro-cap. No pattern recognition. Illiquid conditions. Avoid.
0 · Reply
Latest News on NRC
NRC Health Announces Third Quarter 2025 Results

Oct 27, 2025, 5:00 PM EDT - 2 months ago

NRC Health Announces Third Quarter 2025 Results


Mercy Earns National Honor for Excellence in Patient Experience

Oct 15, 2025, 9:40 AM EDT - 2 months ago

Mercy Earns National Honor for Excellence in Patient Experience


NRC Health Honors 2025 Leaders in Patient Experience and Loyalty

Oct 15, 2025, 6:45 AM EDT - 2 months ago

NRC Health Honors 2025 Leaders in Patient Experience and Loyalty


NRC Health Announces Shane Harrison as Chief Financial Officer

Aug 28, 2025, 8:00 AM EDT - 4 months ago

NRC Health Announces Shane Harrison as Chief Financial Officer


NRC Health Announces Second Quarter 2025 Results

Jul 28, 2025, 5:00 PM EDT - 5 months ago

NRC Health Announces Second Quarter 2025 Results


NRC Health Announces First Quarter Results

Apr 28, 2025, 5:00 PM EDT - 8 months ago

NRC Health Announces First Quarter Results


National Research Corporation Declares Quarterly Dividend

Mar 24, 2025, 5:00 PM EDT - 9 months ago

National Research Corporation Declares Quarterly Dividend


National Research Corporation Announces Fourth Quarter Results

Jan 27, 2025, 5:00 PM EST - 11 months ago

National Research Corporation Announces Fourth Quarter Results


National Research Corporation Announces Third Quarter Results

Oct 25, 2024, 5:00 PM EDT - 1 year ago

National Research Corporation Announces Third Quarter Results


Top 5 Health Care Stocks That May Explode In July

Jul 8, 2024, 8:40 AM EDT - 1 year ago

Top 5 Health Care Stocks That May Explode In July

CSTL OMI PCRX SAVA


National Research Corporation Declares Special Dividend

Sep 6, 2023, 5:00 PM EDT - 2 years ago

National Research Corporation Declares Special Dividend


Bryan Health Chooses NRC Health as Patient Experience Partner

Jul 12, 2023, 11:51 AM EDT - 2 years ago

Bryan Health Chooses NRC Health as Patient Experience Partner


NRC Health reveals 2023 Pediatric Experience Perspective

Apr 6, 2023, 10:00 AM EDT - 2 years ago

NRC Health reveals 2023 Pediatric Experience Perspective


DavyDaveCharts
DavyDaveCharts Dec. 14 at 4:45 PM
$NRC watching 18s for potential breaker. weekly chart.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 12 at 1:45 AM
$NRC Share Price: $17.44 Contract Selected: Jun 18, 2026 $20 Calls Buy Zone: $0.68 – $0.84 Target Zone: $1.27 – $1.55 Potential Upside: 76% ROI Time to Expiration: 188 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:33 PM
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 11 at 11:24 AM
$NRC Share Price: $14.49 Contract Selected: Jun 18, 2026 $15 Calls Buy Zone: $0.99 – $1.23 Target Zone: $1.58 – $1.93 Potential Upside: 50% ROI Time to Expiration: 218 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Oct. 31 at 6:50 PM
$NRC popped 12% even with earnings down — here’s why investors are cheering. 📊 Higher interest costs weighed on Q3, but margin gains, solid cash flow, and a 33% dividend hike more than balanced the hit. See the full picture behind NRC Health’s surprising strength 👉 https://www.zacks.com/stock/news/2782887/nrc-stock-up-12-despite-q3-earnings-down-yy-on-rising-interest-costs?cid=sm-stocktwits-2-2782887-teaser-18926&ADID=SYND_STOCKTWITS_TWEET_2_2782887_TEASER_18926
0 · Reply
ZacksResearch
ZacksResearch Oct. 31 at 5:50 PM
Is $NRC Health’s surge a sign of things to come? 🚀 📈 Stock up 12.3% since earnings, outpacing the S&P 500 💰 Adjusted EBITDA jumped 11%, with margins expanding to 31.4% 🔄 Total Recurring Contract Value climbed 8%, marking strong subscription growth Despite declines in adjusted net income and total revenues, discover what’s driving NRC’s momentum here 👉 https://www.zacks.com/stock/news/2782887/nrc-stock-up-12-despite-q3-earnings-down-yy-on-rising-interest-costs?cid=sm-stocktwits-2-2782887-body-18888&ADID=SYND_STOCKTWITS_TWEET_2_2782887_BODY_18888
0 · Reply
StockScanners
StockScanners Oct. 29 at 2:09 AM
$NRC keep watch if this hold above 12.85
0 · Reply
topstockalerts
topstockalerts Oct. 28 at 4:20 PM
$NRC curling back up
0 · Reply
Uneducated_Trader
Uneducated_Trader Oct. 28 at 2:04 PM
$NRC another stock AI told me to buy on Friday. Thanks AI 👍
0 · Reply
InvisibleHandTrades
InvisibleHandTrades Oct. 5 at 2:12 PM
$NRC Technology services micro-cap. No pattern recognition. Illiquid conditions. Avoid.
0 · Reply
Jutski_bipolar
Jutski_bipolar Oct. 2 at 2:05 PM
$NRC Time for a swing pump
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 3:59 PM
$NRC Great piece that accurately captures NRC's current position. So if you want to refresh your understanding of NRC or learn about NRC for the first time, this is essential reading. https://beyondspx.com/quote/NRC/nrc-health-s-strategic-pivot-investing-in-human-understanding-and-ai-for-future-growth-nasdaq-nrc#analysis
0 · Reply
ZacksResearch
ZacksResearch Aug. 1 at 6:23 PM
$NRC posts Y/Y earnings growth in Q2 — but margin hit raises eyebrows 💡📉 Cost control and TRCV gains drove the improvement, though a one-time exec expense pressured profitability. Full report here 👉 https://www.zacks.com/stock/news/2650472/nrcs-q2-earnings-rise-yy-on-cost-control-and-trcv-growth?cid=sm-stocktwits-2-2650472-teaser-5560&ADID=SYND_STOCKTWITS_TWEET_2_2650472_TEASER_5560
0 · Reply
ZacksResearch
ZacksResearch Aug. 1 at 4:54 PM
$NRC stock slump — time to panic or reassess? 🤔 📉 Shares plunged 24.4% over the past month, outpacing the S&P 500's 2.1% growth. 💼 Despite the net loss, adjusted net income rose slightly year-over-year, and recurring revenue momentum is strong with a 2% sequential growth. Full analysis here 👉 https://www.zacks.com/stock/news/2650472/nrcs-q2-earnings-rise-yy-on-cost-control-and-trcv-growth?cid=sm-stocktwits-2-2650472-body-5512&ADID=SYND_STOCKTWITS_TWEET_2_2650472_BODY_5512
0 · Reply
Wisenheimer
Wisenheimer Jul. 29 at 2:33 PM
$NRC board should be replaced - CEO sign on bonus got pumped up in valuation with the buyback in the qtr shameful
0 · Reply
PenkeTrading
PenkeTrading Apr. 3 at 1:00 PM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of National Research Corp. Is that bullish or bearish? $NRC #RsiOversold #NASDAQ
0 · Reply
d_risk
d_risk Mar. 17 at 6:38 PM
$NRC - National Research Corporation Common Stock (Delaware) - 10K - Updated Risk Factors NRC's 2025 risk factors highlight increased client concentration, new competition from Qualtrics, geopolitical tensions, persistent inflation, AI challenges, cybersecurity threats, strategic partnership risks, executive turnover, and potential tax law changes. #Risk https://d-risk.ai/NRC/10-K/2025-03-17
0 · Reply
CharlieMungersghost
CharlieMungersghost Feb. 28 at 3:53 PM
$NRC long boys riding this to zero lmao Elon and doge gonna kill it
0 · Reply
CharlieMungersghost
CharlieMungersghost Feb. 28 at 3:51 PM
$NRC Oops again 🤣
0 · Reply
munboxfinance
munboxfinance Feb. 26 at 7:27 PM
$NRC has risen in today's early trading hours to $15.97 and went down to $14.78 at the previous close of the morning session. Even so, it's a good option to buy, with an 'A' rating from Schwab and buy recommendations from CFRA, dating back to February 21st.
0 · Reply
CharlieMungersghost
CharlieMungersghost Jan. 28 at 6:54 PM
$NRC told ya
0 · Reply
CharlieMungersghost
CharlieMungersghost Jan. 28 at 6:53 PM
$NRC oops 😬
1 · Reply